AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Novo Nordisk, Eli Lilly and the GLP-1 economy
Unhedged
Intro
This chapter explores the projected market growth and transformative effects of GLP-1 weight loss drugs on obesity treatment. It discusses the skepticism surrounding the hype, their implications for health systems and insurance, as well as current usage and challenges such as side effects.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode